We are a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy. Using its Life Changing Technology and data from its LifeWatches, it encourages wearer wellness-centered lifestyles, consumer data empowerment and generates revenue from data sales that drive the self-funding, Digital Health Sharing Economy.
Helo’s Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data-rich platform collects health data from the users, which we analyze and use AI to prepare customized and personalized user reports, user alerts, and user NutraPak supplements. In addition, our platform also presents Big Data opportunities for developers, medical research, and diagnostics.
Helo Corp Welcomes Clayton Jones as Chief Legal Officer
Helo Corp Welcomes Clayton Jones as Chief Legal Officer
Press Release | 04/06/2022
SAN FRANCISCO, CA / ACCESSWIRE / April 6, 2022 / Helo Corp. (OTC PINK:HLOC) (“Helo” or the “Company”), a leading developer of wearable devices at the forefront of digital health and data-driven wellness, is pleased to announce that Clayton Jones has joined its executive team as chief legal officer, effective March 31, 2022.
“We are delighted to welcome Clayton to our executive team,” said Seán McVeigh, Helo’s chief executive officer. “He brings significant insights and experience, including with other leading technology and wellness companies. We are confident that Clayton will further strengthen our executive team, as we work to grow our business globally.”
Mr. Jones, 45, served as vice president and general counsel of GrÅv Technologies from August 2020 to March 2022. From June 2008 to July 2020, he served as vice president and deputy general counsel, and in other roles at Nu Skin (NYSE: NUS). Prior to that, he practiced business and securities law at Dorsey & Whitney. Mr. Jones received J.D and M.B.A. degrees from the University of Oregon and a B.S. in Economics from Brigham Young University.
“Helo is transforming the wearable technology and wellness industries through integration of blockchain technology and artificial intelligence,” said Mr. Jones. “The Company’s continual innovation and commitment to empowering consumers has created a unique platform and a dynamic culture, which are very compelling. I am excited to join the Helo team.”
About Helo Corp.
Helo Corp. (OTC: HLOC) is a data-driven wellness technology company at the forefront of the Digital Health Sharing Economy. Helo uses its life watches and other personal devices, and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and consumer data empowerment under the Vyvo TM brand and to power the self-funding, Digital Health Sharing Economy. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our customers with tokens to continuously build up our shared bio-bank through self-tracking. Our data rich platform empowers our customers to own and control their bio-metric data, while providing AI-formulated personalized reports and alerts, as well as customized Nutrapak supplements. Our platform also presents Big Data opportunities for technology development, medical research and diagnostics.
For further information on Vyvo and Helo, please click on the links:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates, but involve several unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Helo Corp Announces Record Annual 2021 Results with $64.7 Million of Revenue or 276% Growth
Press Release | 04/04/2022
SAN FRANCISCO, CA / ACCESSWIRE / April 4, 2022 / Helo Corp.(OTC:HLOC) (“Helo” or the “Company), a leading developer of wearable devices at the forefront of digital health and data-driven wellness, is pleased to announce its annual 2021 results.
“The significant improvements achieved this year have been generated from our continued technology advances and the change in our business model, as we sell our products and services to wellness consumers worldwide under the VyvoTM brand,” said Sean McVeigh Chief Executive Officer. “I was very pleased with the strong performance of our Asian markets, which led us to a record-breaking year. We continue to navigate challenges related to COVID-19, including restrictions on in-person meetings and supply chain delays. With a strong product pipeline, robust business model and our planned expansion into sizable new markets, we look forward to growth opportunities in the future.”
“We are excited with our annual revenue of $64.7 million in 2021, a growth rate of 276%” added Ryan Wood, Chief Financial Officer. “Gross margin decreased by 180 basis points to 68.7%, but our overall profitability grew by $10.2 million due to an increase in revenue and a decrease in SG&A as a percent of revenue. Earnings per share was $0.12 for the year. We ended the year with a strong balance sheet with total assets of $27.8 million and no debt.”
About Helo Corp.
Helo Corp. (OTC: HLOC) is a data-driven wellness technology company at the forefront of the Digital Health Sharing Economy. Helo uses its life watches and other personal devices and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and consumer data empowerment under the Vyvo TM brand and to power the self-funding, Digital Health Sharing Economy. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our customers with tokens to continuously build up our shared bio-bank through self-tracking. Our data rich platform empowers our customers to own and control their bio-metric data, while providing AI-formulated personalized reports and alerts, as well as customized Nutrapak supplements. Our platform also presents Big Data opportunities for technology development, medical research and diagnostics.
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Helo Corp Subsidiary Vyvo Inc Welcomes New Chief Executive Officer
Press Release | 03/16/2022
SAN FRANCISCO, CA / ACCESSWIRE / March 16, 2022 / Helo Corp. (OTC PINK:HLOC) (“Helo” or the “Company”), a leading developer of wearable, wireless devices and a pioneer at the forefront of digital health, is pleased to announce that Helo Corp.’s board of directors has appointed Robert “Bo” Short as chief executive officer of Vyvo Inc., a wholly owned subsidiary of Helo Corp., to develop, implement and lead its growth, beginning with its U.S. launch and subsequent global expansion.
Helo Corp.’s CEO Seán McVeigh, said “I am delighted to welcome Bo Short to Vyvo. He brings to this team the undisputed success of a team-builder, the insights and understanding of a company owner, and the much-sought-after skills of an exceptional business leader. We recognize Bo’s experience, and we are excited to work with Bo as he leads our U.S. launch and subsequent global expansion.”
Short has spent 32 years in the direct selling industry and has built teams in 100 countries. He is a legendary leader and currently ranks as one of the top lifetime income earners in the industry. He has also owned two direct selling companies and has served in C-level positions in two companies. Short also brings leadership expertise from outside of the direct sales industry. As former president of the American Leadership Foundation, he’s reached more than 1 million people in 34 countries with his insights on leadership and personal development. His bestselling books include The Foundation of Leadership and Living to Win. He has appeared on numerous radio and television broadcasts as a leadership expert.
About Helo Corp.
Helo Corp. (OTC PINK:HLOC) is a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy. Using its Life-Changing Technology and data from its Vyvo LifeWatches, it encourages wearer wellness-centered lifestyles, consumer data empowerment and generates revenue from data sales that drive the self-funding, Digital Health Sharing Economy.
Helo’s Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. Under the Vyvo brand, Vyvo incentivizes our userbase with Vyvo Coins mined using their Vyvo LifeWatch, to continuously build up our shared bio-bank through self-tracking. Our two-sided data-rich platform collects health data from the users which we analyze and use AI to prepare customized and personalized user reports, user alerts, and user NutraPak supplements. In addition, our platform also presents Big Data opportunities for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates, but involve several unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Helo Corp Welcomes the Addition of New Chief Financial Officer
Press Release | 03/07/2022
SAN FRANCISCO, CA / ACCESSWIRE / March 7, 2022 / Helo Corp. (OTC PINK:HLOC) (“Helo” or the “Company”), a leading developer of wearable, wireless devices and a pioneer at the forefront of digital health, is pleased to announce that Helo Corp.’s board of directors has elected Ryan C. Wood as chief financial officer, Helo Corp., effective March 2, 2022.
Wood reports to Seán McVeigh, chief executive officer and he succeeds McVeigh as chief financial officer. McVeigh remains as chief executive officer. “I am confident that Ryan will strengthen our leadership team with his strategic, financial and business acumen, and will help our company continue to grow and perform,” said McVeigh. He continued, “Ryan has broad and relevant experience and has a proven track record of effectively leading finance organizations and driving business results.”
Wood 43, served since August 2017 as vice president of global financial planning and analysis for Nu Skin Enterprises, a US publicly traded multilevel marketing company that develops and sells personal care and dietary supplements. From May 2007 to August 2017, Wood held many different positions in accounting and finance at Nu Skin Enterprises. Wood started his career as an audit associate for KPMG. Wood holds a bachelor’s degree in finance and a Master of Accountancy degree from Brigham Young University.
About Helo Corp.
Helo Corp. (OTC PINK:HLOC) is a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy. Using its Life-Changing Technology and data from its Vyvo LifeWatches, it encourages wearer wellness-centered lifestyles, consumer data empowerment and generates revenue from data sales that drive the self-funding, Digital Health Sharing Economy.
Helo’s Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. Under the Vyvo brand, Vyvo incentivizes our userbase with Vyvo Coins mined using their Vyvo LifeWatch, to continuously build up our shared bio-bank through self-tracking. Our two-sided data-rich platform collects health data from the users which we analyze and use AI to prepare customized and personalized user reports, user alerts, and user NutraPak supplements. In addition, our platform also presents Big Data opportunities for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates, but involve several unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
SAN FRANCISCO, CA / ACCESSWIRE / February 16, 2022 / Helo Corp. (OTC PINK:HLOC) (“Helo” or the “Company”), a leading developer of wearable, wireless devices and a pioneer at the forefront of digital health, is pleased to announce that it has provided funding to support the development of santéPatch, a technology that claims to enable monitoring of wearer micronutrients.
Helo’s funding will be used to validate the technology and assist in bringing santéPatch to market, where Helo’s subsidiary, Vyvo Technology Corp intends to use the status of the santéPatch wearer’s micronutrient data to inform its AI engine and supply more accurate personalized nutrition to its customers worldwide.
The precision nutrition market is predicted to grow significantly over the next few years. Unhealthy eating habits, hectic lifestyles, and the rising prevalence of various diseases drive demand for personalized nutrition, which in 2020 created a global market of more than US$8 billion. This market is expected to exceed US$24 billion in 2028, according to Research and Markets.
“Under its Vyvo brand, Helo seeks to grow its share of the precision nutrition market using non-invasive technology to measure individual customer mineral and vitamin data to identify their specific deficiencies, so that our customers only take what they need,” said Fabio Galdi, Chairman and CTO of Helo Corp. “We are excited to add the benefits of measuring vitamins and minerals to the already wide range of biomarkers detected by our Life Sensing Technology™, deployed with all our devices. We expect that santéPatch’s technology will provide additional data sources to inform our AI process further and provide even more accurate personalized nutrition to our customers worldwide.
“We seek to bring greater transparency to the nutrition and supplement industry,” he continued, “by using santéPatch technology to demonstrate to our customers the change in their micronutrient levels when they take vitamins and minerals. This approach fits with our corporate vision of using life-changing technology to benefit our customers worldwide.”
According to santéPatch’s founder, Yasar Tunc, “santéPatch uses an advanced biochemical process (called reverse iontophoresis) built into the patch worn on the skin to attract nutrients present in the fluid around skin cells. A spectrometer micro-sensor in the patch non-invasively measures the fluid for nutrients and provides a view of the vitamin and mineral levels present. This data can then be transmitted wirelessly to the cloud for further analysis. The whole process is easy, convenient, pain-free, and real-time (after wearing the patch at least 15 minutes).”
An overview of santéPatch technology is explained in the figure above and in santéPatch’s video.
Helo Corp has provided £150,000 in convertible debt funding to Maverick Group (Investments) Ltd. and Yasar Tunc to support the development of santéPatch. This convertible debt is repayable in 45 days from closing (or by a later date to which the parties agree) together with interest at the annual rate of 5%, unless converted into 16.7% of the equity capital of a company to be formed into which the santéPatch technology, related intellectual property and assets will be transferred.
“We are delighted to support Yasar and the Maverick Group in bringing this exciting technology to market. Helo’s funding intends to fast-track the validation of the santéPatch technology and bring it closer to mass production,” said Helo’s CEO, Sean McVeigh. “As part of this agreement, Helo will obtain a 16.7% share in the company that will hold the IP rights to the santéPatch technology if the debt is converted.”
“In addition,” he continues, “this micronutrient technology could enable Vyvo to become a disruptive player in the supplement industry, allowing it to adopt a demonstrable customer data-driven, decision-making approach to delivering precision nutrition to our customers worldwide.”
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates, but involve several unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
SAN FRANCISCO, CA / ACCESSWIRE / December 23, 2021 / Helo Corp. (OTC PINK:HLOC) (“Helo” or the “Company”), a leading developer of wearable, wireless devices at the forefront of digital health and dedicated to improving wellness worldwide, is pleased to announce that the Vyvo Network Japan KK employees have won the 2021 Helo Chairman’s Award.
The Helo Chairman’s Award recognizes an exceptional individual or team performance that had a significant impact on the Vyvo business. This is the first year for this annual award. It is granted for outstanding achievements such as driving impressive financial results, building strong team performance, and successfully introducing new processes, which contribute to the wellbeing and success of Vyvo and its employees.
The allocation of this award is decided exclusively by the Helo Chairman, Mr. Fabio Galdi. Today, he has announced that the first Chairman’s Award goes to Vyvo’s top-performing office for 2021, Vyvo Network Japan KK.
Fabio Galdi, Helo’s Chairman of the Board, stated that “After much deliberation, I am delighted to select Vyvo Network Japan for this award. Everyone is aware that this past year has been extremely challenging, however, this did not stop Vyvo. I am proud to work with such resilient and resourceful colleagues who hail from all over the world. My only regret is that I cannot present this award personally due to travel restrictions.” He continued, “It was a difficult decision as there were many strong contenders for the Chairman’s Award, in all areas of Vyvo’s business activities. However, the Japanese team, led by their inspirational GM, Mr. Shimizu, excelled in their team approach, which delivered impressive financial results as well the Chairman’s Award for every Vyvo employee in Japan.”
The precise details of the Chairman’s Award, which comes in the form of a January 2022 bonus this year, and is in addition to any other employee performance bonus, will be communicated to the Japanese employees tomorrow by the management of Vyvo Network Japan KK.
About Helo Corp.
Helo Corp. (OTC PINK:HLOC) is a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy. Using its Life-Changing Technology and data from its LifeWatches, it encourages wearer wellness-centered lifestyles, consumer data empowerment and generates revenue from data sales that drive the self-funding, Digital Health Sharing Economy.
Helo’s Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data-rich platform collects health data from the users which we analyze and use AI to prepare customized and personalized user reports, user alerts, and user NutraPak supplements. In addition, our platform also presents Big Data opportunities for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links:
Forward-Looking Statement
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates, but involve several unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Helo Corp Invests to Drive Further Revenue Growth and to Open New Markets in 2022
Press Release | 12/15/2021
SAN FRANCISCO, CA / ACCESSWIRE / December 15, 2021 / Helo Corp.(OTC PINK:HLOC) (“Helo” or the “Company”), a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy, is pleased to confirm that three of its subsidiaries have opened larger offices to support its fast growing business and it is preparing to open new markets in 2022.
As the winner of a 2021 Deloitte Fast 500 Technology Award, Helo Corp has doubled down on its record 2021 growth by increasing staff numbers and securing larger offices in Asia and in the US. These new offices are to ensure a safer operational environment for its employees while providing ongoing support for Vyvo customers and Vyvo promoters worldwide.
Seán McVeigh, Helo’s Chief Executive Officer, confirmed that, “Although the pandemic has been difficult, bringing personal and business challenges, we are thankful to our employees, our customers and our Vyvo promoters worldwide who have helped deliver our record 2021 results. We are now well positioned for strong growth. This year,”he says, “we have been continually investing in hiring new employees, developing our technology and expanding our facilities to ensure sustained growth in our chosen markets. Up to now, all of our growth has been organic. We are now preparing to extend our strategic footprint as we plan to launch new markets in 2022. We expect to enter these new markets by acquisition, joint venture or with organic sales growth.”
Fabio Galdi, Vyvo’s Chief Executive Officer, stated, “We have secured a larger office in the TechMart building, Santa Clara, California. With this new working space, I’m excited to be able to collaborate face to face with our existing and future Silicon Valley based employees so that together we can build and communicate the benefits of our Life Changing Technology to all Vyvo entities and our Vyvo promoters worldwide. These activities at VyvoLabs, “he continued, “will provide the technology foundation on which Vyvo will continue to build and grow.”
Two of Helo Corp.’s three subsidiaries that have moved to new offices are in Asia. Vyvo Network Japan KK’s new office is in the Shinjuku Sumitomo Building in Tokyo’s business area. Vyvo Network Pte Ltd.’s office is in the Zhongzheng District of Taipei, Taiwan. Vyvo has other offices in Miami, Florida, India, Ireland, Italy, Singapore and Thailand.
Vyvo Network Japan KK’s new office:
Vyvo Network Pte Ltd.’s new office in Taipei:
Vyvo Technology Corp.’s Santa Clara office:
About Helo Corp.
Helo Corp. (OTC:HLOC) is a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy. Using its Life Changing Technology and data from its LifeWatches, it encourages wearer wellness-centered lifestyles, consumer data empowerment and generates revenue from data sales that drive the self-funding, Digital Health Sharing Economy.
Helo’s Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data rich platform collects health data from the users which we analyze and use AI to prepare customized and personalized user reports, user alerts and user NutraPak supplements. In addition, our platform also presents Big Data opportunity for developers, medical research and diagnostics.
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Deloitte Confirms Helo Corp is one of the Fastest-Growing Technology Companies in North America
Deloitte Confirms Helo Corp is one of the Fastest-Growing Technology Companies in North AmericaPress Release | 12/01/2021
SAN FRANCISCO, CA / ACCESSWIRE / December 1, 2021 / Helo Corp.(OTC PINK:HLOC) (“Helo” or the “Company”), a leading developer of wearable wireless devices and at the forefront of digital health, is dedicated to improving wellness worldwide and is pleased to announce that it is a winner of a Deloitte Fast 500 Technology Award.
For over two decades, Deloitte has been honoring the most innovative, fastest-growing public and private technology companies that hail from cities across North America. The Technology Fast 500 was created to recognize the passion and dedication it takes to be an industry disruptor. The award is granted by Deloitte to technology innovators in selected industry sectors who own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues, enabling these Technology Fast 500 awardees to achieve impressive growth.
Excerpts from video where Nasdaq rotated Bay Area Fast 500 winning company logos on its massive Times Square Tower Video screen last Friday. Full video, click Nasdaq Fast 500.
This year and for the first time, Helo Corp., trading as Vyvo was chosen by Deloitte to join this elite group of high-achievers who were selected based on their revenue growth from 2017 to 2020. Helo’s percentage fiscal year revenue growth was 679% during these three years, which is well above the Technology Fast 500 median growth rate of 521%. Seán McVeigh, CEO Helo Corp. stated that, “We are delighted to accept this prestigious Deloitte. It is a reflection of our tremendous growth arising from our proprietary and innovative technology, successfully deployed using our updated business model where we sell our products and services to wellness customers worldwide.” He continued, “This award recognizes the dedication of our employees whose efforts have ensured that Helo Corp is well positioned for long term, profitable and sustainable growth.”
“Each year the Technology Fast 500 shines a light on leading innovators in technology and this year is no exception,” said Paul Silverglate, vice chair, Deloitte LLP and U.S. technology sector leader. “In the face of innumerable challenges resulting from the pandemic, the best and brightest were able to pivot, reinvent and transform and grow. We celebrate the winning organizations and especially the talented employees driving their success.”
“This award confirms Vyvo’s leading position at the forefront of digital health,” said Fabio Galdi, Vyvo CEO. He continued, “We are the future makers in our industry. Our life changing technology combined with the power of AI and blockchain allows us to offer unique products and services to the market, while transparently sharing the revenue generated from this data with our Vyvo members.”
Vyvo’s Life Sensing TechnologyTM and patented side sensor of Vyvo’s LifeWatch 2 enables precision measurement of blood oxygen, blood pressure and HRV, as well as continuously monitoring body temperature and many other health and fitness parameters.
In addition to these benefits, Vyvo members can earn revenues just by wearing their Vyvo LifeWatch. Unlike any other watch in the market, Vyvo’s LifeWatches generate utility tokens on the Ethereum ERC-20 blockchain thereby ensuring that Vyvo members get a share of the revenue generated from the sale of Vyvo’s anonymized wearer data. Funding for these utility tokens is generated from the sale of products and services that use Vyvo’s wearer data. In addition, secure access to Helo’s ever-growing database is also provided to universities, researchers, hospitals and for population wellness and other studies which may facilitate medical breakthroughs.
# # #
About Helo Corp.
Helo Corp. (OTC: HLOC) is a wellness technology company at the forefront of digital health and is a pioneer of the Digital Health Sharing Economy. Helo uses data from its LifeWatches to encourage wearer wellness-centered lifestyles, consumer data empowerment and to generate revenue from data sales that drive the self-funding, Digital Health Sharing Economy.
Helo’s Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data rich platform collects health data from the users which we analyze and use AI to prepare customized and personalized user reports, user alerts and user NutraPak supplements. In addition, our platform also presents Big Data opportunity for developers, medical research and diagnostics.
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
Helo Corp. Announces Record third quarter 2021 Results with 1395% Increase to $52.8 Million Revenue and $9.9 Million Net Income for $0.11 EPS
Press Release | 11/22/2021
SAN FRANCISCO, CA / ACCESSWIRE / November 22, 2021 / Helo Corp.(OTC PINK:HLOC) (“Helo” or the “Company), a leading developer of wearable wireless devices at the forefront of digital health and dedicated to improving wellness worldwide, is pleased to announce its third quarter 2021 results and alternative filing with OTC Markets.
Revenue for this year to end of September, 2021 increased from the same period last year by $49.2 million or 1395% to $52.8 million. The increase in revenue was primarily due to the change in Helo Corp.’s business model providing products and services to wellness consumers worldwide under the VyvoTM brand.
Gross profit for this year ended September 30, 2021 increased by $17.4 million to $18.2 million.
Gross margin for this year to end of September, 2021 increased by 110 basis points to 34%, from 23% for the same period last year.
Operating income for this year to end of September, 2021 increased to $10.7 million, from the same period last year.
Net income for the year to end of September, 2021 increased to $9.9 million, from the same period last year.
Total assets at the end of September, 2021 increased by $17.0 million to $23.5 million.
The resulting positive EPS for this year to end of September, 2021 was $0.11, as compared to a negative EPS of ($0.01) for the same period last year.
Sean McVeigh, Helo’s Chief Executive Officer, commented, “The significant improvments achieved this year have been generated from our continued technology advances and the change in our business model, as we sell our products and services to wellness consumers worldwide. We expect our strong growth to continue for the rest of this year, into next year and beyond as we project continued solid sales in Asia and as we open up new markets.”
Fabio Galdi, Vyvo’s Chief Executive Office, stated, “Our continued innovation combined with the efforts of Vyvo members and our employees has driven our impressive growth. Vyvo’s position at the forefront of digital health is now well established and we look forward to building a sustainable, self-funding Digital Health Sharing Economy, where all participants prosper.”
About Helo Corp.
Helo Corp. (OTC: HLOC) is a wellness technology company at the forefront of digital health and a pioneer of the Digital Health Sharing Economy. Helo uses its life watches and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles, consumer data empowerment under the Vyvo TM brand and to power the self-funding, Digital Health Sharing Economy. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data rich platform collects health data from the users which we analyze and use AI to formulate customized and personalized user reports, user alerts and Nutrapak supplements, and our platform also presents Big Data opportunity for developers, medical research and diagnostics.
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
San Francisco, CA May 19, 2021 Helo Corp. (OTC: HLOC) (Helo or the Company), a leading developer of wearable wireless devices and bio-data informed personalized products and services, dedicated to improving wellness worldwide, is pleased to announce its full year 2020 audited results and alternative filing with OTC Markets.
Revenue for the full year ended December 31, 2020 increased by $15.2 million, or 760%, to $17.2 million, from $2.0 million for the year ended December 31, 2019. The increase in revenue was primarily due to the launch of its second-generation products, expanded product range and change of its business model from September 1, 2020.
Gross profit for the full year ended December 31, 2020 increased by $4.7 million, or 1175%, to $5.2 million, from $0.4 million for the year ended December 31, 2019.
Gross margin for the full year ended December 31, 2020 increased by 80 basis points to 29%, from 21% for the year ended December 31, 2019.
Operating income for the full year ended December 31, 2020 increased $2.6 million to $1.5 million, from an operating loss of $1.1 million for the year ended December 31, 2019.
Net income for the full year ended December 31, 2020 increased $2.9 million to $1.3 million, from a net loss of $1.6 million for the year ended December 31, 2019.
The resulting positive EPS for the full year ended December 31, 2020 was $0.04, as compared to a negative EPS of ($0.04) for the year ended December 31, 2019.
Sen McVeigh, Helos Chief Executive Officer, commented, 2020 was a significant year for us as we launched our second-generation devices and took action to capture more of our downstream value chain. In September, 2020 increased our range of products and services and we moved away from our traditional wholesale business model. We opened our consumer e-commerce portal and used it to convert customer referrals to sales. As seen by the upswing in the last quarter of 2020, these changes have set the stage for accelerated growth and profitability for 2021 and years to come.
Fabio Galdi, Vyvos Chief Executive Office, stated, Our patented technology, recurring revenue from our digital reports and NutraPak sales, combined with our leadership in the Digital Health Sharing economy where our Vyvo wearers get paid for their data, ensures that we will achieve our strategic goal to build a growing community of loyal customers in the wellness market. Galdi continued, We look forward to opening up our Digital Health Sharing economy to new partners who seek to access our anonymized bio-metric database and bring further value to our Vyvo members.
Helo Corp launched its second-generation products and new products in 2020:
Watch LiteLaunched January, 2020, Watch Lite is an Ultra-thin (7mm thick) Life Watch with data collection capabilities that enable features such as continuous atrial fibrillation detection, mood and energy monitoring, fall detection, blood oxygenation measurement capability and sleep apnea detection.
Watch Lite Special Editionis a Watch Lite with the addition of a Texas Instruments high precision, medical-grade digital temperature sensor capable of providing body temperature readings with an accuracy of up to 0.1C, complying with the ASTM E1112 and ISO 80601-2-56 standards. The first Watch Lite Special Edition was shipped in June 2020.
Watch Generation 2is the Companys flagship Life Watch, with its US patent pending fingertip side sensor enabling high quality measurements such as Blood Pressure and blood oxygenation, together with the complete suite of sensors and services offered by Vyvo. The first Watch 2 was shipped by the Company in September 2020. For an overview of Vyvos Life Watch Generation 2, please click on the icon[1].
NutraPak and Digital Services
From September 1, 2020, the Company changed its business model to sell to wellness consumers its generation 2 devices and additional products. These include NutraPak, a continuously updated, personalized, customer specific easy-melt supplement which we deliver to our customers door and a range of Oracle AI personalized services which are delivered electronically. All of our new products and services are enabled using our customer (and VyvoPay rewarded) updated data, gathered by Vyvo devices worn by our customers worldwide.
About Helo Corp.
Helo Corp. (OTC: HLOC) is a wellness technology company at the forefront of the digital health sharing economy, using life watches and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and enabling consumer data empowerment under the Vyvo brand. Our Life Sensing TechnologyTMuses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided, data rich platform collects health data from the users which we analyze and use AI to formulate customized and personalized user reports, user alerts and Nutrapak supplements, and our platform also presents Big Data opportunity for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links below:
This news release contains forward-lookingstatements within the meaning of Section 27A of the Securities Act of 1933, asamended, and Section 21E of the Securities ExchangeAct of 1934, as amended,and as defined in the U.S. Private Securities Litigation Reform Act of 1995.These forward-looking statements can be identified by terminology such asmay, will,expects, anticipates, future, intends, plans, believes, estimates,potential and similar statements. All statements other than statements ofhistoricalfact in this press release are forward-looking statements andinvolve certain risks and uncertainties that could cause actual results todiffer materially from those in the forward-looking statements. Theseforward-looking statements are based on managements current expectations,assumptions, estimates and projections about the Company and theindustry inwhich the Company operates, but involve a number of unknown risks and uncertainties.Further information regarding these and other risks is included in theCompanysfilings with the OTC Markets and the Securities and Exchange Commission. TheCompany undertakes no obligation to update forward-looking statements toreflectsubsequent occurring events or circumstances, or changes in itsexpectations, except as may be required by law. Although the Company believesthat the expectations expressed inthese forward-looking statements arereasonable, it cannot assure you that such expectations will turn out to becorrect, and actual results may differ materially from theanticipated results.You are urged to consider these factors carefully in evaluating theforward-looking statements contained herein and are cautioned not to place unduerelianceon such forward-looking statements, which are qualified in theirentirety by these cautionary statements.
Helo Corp.’s Patent Pending Side Sensor Enables Vascular Age Assessment on its Vyvo Life Watch 2
SAN FRANCISCO, CA / ACCESSWIRE / February 10, 2021 / Helo Corp. (OTC:HLOC) (“Helo” or the “Company), a leading developer of wearable wireless devices embedded with Life Sensing TechnologyTM and dedicated to improving wellness worldwide, is pleased to announce that with its latest Vyvo Smart app update, it provides rapid, non-invasive Vascular Age assessment to all Vyvo Life Watch 2 users worldwide.
Vyvo’s patent-pending side sensor captures high-quality fingertip photoplethysmogram (PPG) signals[1] on demand. Accelerated Plethysmography[2] (APG), which uses the second derivative of PPG waveform, is used to analyze the wearer’s arterial stiffness and estimate their Vascular Age. The whole process takes less than a minute.
Figure: Vyvo Life Watch 2 with patent-pending side sensor and APG result displayed on the Vyvo Smart app.
Understanding the health of your cardiovascular system is paramount, because according to the World Health Organization, more people die annually from cardiovascular disease (CVD) than from any other cause, amounting to 17.9 million people or an estimated 31% of all deaths worldwide.
There are many ways to assess your Vascular Age, such as booking an appointment at a clinic where they can have advanced ultrasound technology, which can be used as an early biomarker of CVD and risk. Alternatively, your doctor may suggest one or more diagnostic tests, such as blood tests, Doppler ultrasound, Cardiac catheterization and angiogram, or other imaging tests. The challenge with CVD is that it is clinically silent (despite ongoing disease progression) so people at risk do not know to visit their doctor or clinic.
“You’re as old as your arteries, which doesn’t always equal the number of candles on your birthday cake.” according to Harvard Medical School[3]. In young individuals, arteries are more elastic[4], but as we age, our arteries stiffen, and APG has been found to be useful for the estimation of risk of coronary heart disease in the general population[5].
Seán McVeigh, CEO of Helo Corp says that “APG technology is becoming more mainstream and it is already being used at clinics throughout the US, but so far, nobody has combined non-invasive Vascular Age assessment with the convenience of a wearable device. Our patent-pending side sensor has enabled this feature. Our users understand that our Life Watch 2 is not a medical device but it can provide a possible early warning and they should seek expert medical advice if they find that their Vascular Age is significantly greater than their chronological age.”
About Helo Corp.
Helo Corp. (OTC:HLOC) is a wellness technology company in the digital health sharing economy using life watches and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and consumer data empowerment under the Vyvo brand. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data rich platform collects health data from the users, which we analyze and use AI to formulate customized and personalized user reports, user alerts, and NutraPak supplements, and our platform also presents Big Data opportunity for developers, medical research, and diagnostics.
Vyvo Life Watch 2 wearers can upgrade your App using Google Play or Apple’s App Store.
For further information on Vyvo and Helo, please click on the links below:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
SAN FRANCISCO, CA / ACCESSWIRE / February 2, 2021 / Helo Corp. (OTC PINK:HLOC) (“Helo” or the “Company), a leading developer of wearable wireless devices embedded with Life Sensing TechnologyTM and dedicated to improving wellness worldwide, is pleased to announce that Vyvo has received a Platinum and Two Gold awards at the 15th annual AVA Digital Awards.
One of the Vyvo Life Watch videos can be viewed below[1]:
For more detailed information and a complete list of winners honoring web production, digital marketing, digital video creation, pro-bono excellence, administered by the Association of Marketing and Communication Professionals, please visit: https://avaawards.com.
The AVA Awards were awarded for Vyvo’s Life Watch digital campaign launch and had been awarded a Platinum Award for the category of Digital Video Creation, Motion Graphics Product. Vyvo also received two Golds: the first for their Social Campaign in the category of Video Production, Commercials, Product, and the latter in the category of Web-Based Production, Short Form Web Video – under 3 Minutes, Healthcare.
The second award winning video can be viewed below[2]:
“I’m both incredibly honored and proud of what we have accomplished with our launches of life-changing technologies like in our Life Watch Generation 2. The fact that we have continued receiving recognition from peers in the industry, and specifically for how we are sharing the message about the impact our Digital Health Sharing Economy can have, not only serves to affirm that everyone on the Vyvo Journey is on the smart path to success,” commented Vyvo CEO Fabio Galdi.
The collection of accolades that Vyvo has recently received showcases the strength of their message, highlighting that Vyvo’s offering is not just a Life Watch that collects your data; it is a Life Watch that powers an emerging Digital Health Sharing Economy that’s growing quickly and is a first in the direct selling space. Vyvo has been on point in reaching their audiences with compelling and informational content that shows the great potential of their unique and lucrative home-based tech opportunity – catering to every individual’s financial goals and flexibility.
About Helo Corp.
Helo Corp. (OTC PINK:HLOC) is a wellness technology company in the digital health sharing economy using life watches and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and consumer data empowerment under the Vyvo brand. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data rich platform collects health data from the users which we analyze and use AI to formulate customized and personalized user reports, user alerts and Nutrapak supplements, and our platform also presents Big Data opportunity for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links below:
Forward-Looking Statement
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
San Francisco, CA – Accesswire – January 14, 2021 — Helo Corp. (OTC: HLOC) (“Helo” or the “Company), a leading developer of wearable wireless devices embedded with Life Sensing TechnologyTM and dedicated to improving wellness worldwide, is pleased to announce the closing of its acquisition of Vyvo Inc. (“Vyvo”) on January 1, 2021, which transfers the Vyvo business into a publicly traded entity. Vyvo is building a worldwide community of passionate users who leverage technology to live healthier and happier lives with greater prosperity.
The all stock transaction encompasses the issuance by Helo of 50 million common shares, 100 Preferred A Super Voting shares and 2 million Preferred B shares in exchange for Vyvo’s strategic assets, including patents, technologies and operational assets. These assets include Nutramatic, GlucoStrap, Artificial Intelligence(AI) protocols and machine learning processes and Vyvo Network Software. As part of the transaction, $1.8 million of Helo’s debt was forgiven. In addition, Vyvo members who are already shareholders will automatically attain shares in HLOC.
This transaction, effective January 1, 2021 has enabled Helo Corp. to secure all of the technological assets and capabilities necessary to transition from a wholesale device business to a business-to-consumer business model where HLOC secures increased revenues from the sale of its devices (as it captures a greater portion of the value chain) and additional revenues from the sale of other Vyvo products and services.
Sean McVeigh, Helo’s Chief Executive Officer, commented, “This transaction that brings Vyvo public is a major milestone for us and we wish to thank all who made it possible. We look forward to executing on our strategic plan by capitalising on Vyvo’s leading position in the digital health industry, and building shareholder value for our holders, employees, partners and Vyvo members.”
Fabio Galdi, Vyvo’s Chief Executive Office, stated, “Going public has always been part of the Vyvo’s mission and now that we have achieved this important objective, we can bring even more value to Vyvo members who, as shareholders, will continue to promote Vyvo going forward, securing Vyvo’s revenue stream. We will utilize our new public currency as an incentive and retainment tool for our members in order to build shareholder value.”
Vyvo’s established global presence and network marketing approach, combined with social selling enables it to reach consumers worldwide. The Company has 80+ employees in 10 locations, spanning USA, Japan, Taiwan, India, China, Singapore, Thailand, Russia, Italy and Ireland. According to Fabio Galdi, Vyvo’s customer acquisition process is simple and highlights that one of the key revenue drivers is that Vyvo users who are passionate about Vyvo’s product offering and who choose to promote Vyvo to other potential users, receive a commission when the prospect becomes a Vyvo customer by placing an order directly with Vyvo. With this approach, Vyvo has established business in Asia and is preparing its North America launch in the second quarter of 2021.
According to the Deloitte’s video “The Future of Health”, Deloitte states that, “20 years from now, radically interoperable data and open and secure will allow consumers to own their own journey of health.” Click on the icon to view Deloitte’s video[1]:
Fabio Galdi states that “We have the technology and capability so we are not willing to wait until 2040. We are already building many aspects of the “The Future of Health” ecosystem outlined in the Deloitte video. Vyvo users today enjoy features such as Guardian Alert, which can detect changes or deviations in their vital signs so they are alerted and can take immediate action. Our users also benefit from personalized AI generated reports and customized products, based on their data (similar to “precision medicine”). In addition, in this age where individual rights and privacy is being challenged, Vyvo will provide users with their own unique cryptographic key so they are in control of their data. only Vyvo users hold their own Etherium blockchain private cryptographic key which allows them to be in full control of their data all of the time. With all of these elements in place, we believe that Vyvo has created the first self-funded, “Digital Health Sharing Economy” because we use blockchain technology to share the revenue generated from Digital Health industry, expected to reach US$833 billion by 2027[2] with these users themselves. We actually pay our users for their data which is automatically gathered when they wear our Vyvo Life Watch!”
For an overview of Vyvo’s LifeWatch Generation 2, please click on the icon[3]:
Helo Corp. (OTC: HLOC) is a wellness technology company in the digital health sharing economy using life watches and its proprietary bio-metrics data platform to encourage wellness-centered lifestyles and consumer data empowerment. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing, and algorithms to collect and process specific bio-parameters for the user and Healthtech market. We incentivize our userbase with Vyvo Utility Tokens to continuously build up our shared bio-bank through self-tracking. Our two-sided data rich platform collects health data from the users which we analyze and use AI to formulate customized and personalized user reports, user alerts and Nutrapak supplements, and our platform also presents Big Data opportunity for developers, medical research, and diagnostics.
For further information on Vyvo and Helo, please click on the links below:
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
San Francisco, California May 20, 2020 – Helo Corp. (OTC: HLOC) (Helo Corp), a leading developer of wearable devices embedded with Life Sensing TechnologyTM and dedicated to improving wellness worldwide, today invites health researchers and medical professionals to join its Project CEASE (COVID-19 Early Alert System Experiment) to help format and analyze its anonymized VYVO smartwatch wearer data to see if data patterns gathered from its wellness devices can be used to indicate the onset of a viral infection, such as COVID-19.
Helo Corps smartwatch data is already being used in an early alert system called Guardian Alert, which is available to VYVO smartwatch wearers who have pre-selected their guardians for notification if their data indicates that they have fallen or they have had an Atrial Fibrillation episode or a sleep apnea event. In addition, the Guardian Alert system notifies guardians if the wearers breath rate, heart rate, blood oxygenation and temperature are outside of their normal ranges.
Although Helo Corps non-invasive devices are intended only for general wellness use and provide personal tracking as part of promoting a healthy lifestyle, we believe the data that these devices gather will provide useful insights for participants in Project CEASE, both VYVO smartwatch wearers and the health and medical professionals who join us. In addition, Project CEASE data will soon be enhanced with data from VYVOs latest devices which are currently in production and use medical grade sensors for temperature measurement. These sensors provide 0.1C accuracy from 30 to 45C (86 to 113F) and meet the American Society for Testing and Materials (ASTM) E1112 and International Organization for Standardization (ISO) 80601 requirements for patient thermometers.
Helo Corp is asking VYVO smartwatch wearers to share their ongoing bio-data gathered from their VYVO smartwatch and to complete a health status questionnaire, which will includes results from the rapid antibody COVID-19 test kit that is being provided to wearers that participate in Project CEASE. These test kits with two separate tests included, have already been sourced from approved manufacturers and selected for participants depending on the participants location, to ensure compliance with their local country regulations. Test kits are being provided to participants to standardize participants infection status feedback across the project.
Project CEASE is being conducted in three phases. The first phase of data collection will commence when existing VYVO smartwatch wearers opt-in to sharing their bio-data using their VYVO Smart App. The Algorithm Training Phase, the second phase, will commence once sufficient data has been gathered to train our AI algorithm to identify possible data patterns that may indicate the presence of a viral respiratory infection. The third or Validation Phase, is where the trained AI algorithm is applied to Project CEASE participants whose infection status is unknown. If a high probability of an influenza-like infection is detected in a participants data, they will receive an Early Alert notification (similar to the image below). To validate the notification as generated by the AI algorithm, the participant will be requested to consult with their doctor and, if so advised, undertake and share the result of their COVID-19 test.
Simulated Guardian Alert notification image.
Helo Corp believe the collection and aggregation of the bio-data of our smartwatch customers may be beneficial to the broader healthcare community. Consequently, Helo Corp is reaching out to medical doctors, professional researchers, healthcare providers, government bodies, hospitals, universities and commercial entities with project relevant capabilities to join Project CEASE to assist Helo Corp in framing the scope and format of the bio-data that we collect in a way that would be most useful. The broader goal of Project CEASE would be to gather and make available Helo Corps aggregated, anonymized wearer data and Artificial Intelligence (AI) to assist the healthcare community to identify data patterns which might be used by them to indicate the onset of a viral infection, such as COVID-19. This aggregated, anonymized wearer data is available free to all approved research partners while Project CEASE remains active.
Fabio Galdi, CTO and Chairman of Helo Corp, said that To ensure Project CEASE is meaningful on a worldwide scale, we are looking for at least 25,000 VYVO smartwatch wearers to contribute their data. The good news is that we believe we can easily achieve this level of participation with our existing VYVO smartwatch wearers. Using this crowd sourced, cloud based real-time data collection process, together with the power of big data analysis and machine learning, we expect to be able to provide bio-data that will indicate patterns and trends to assist in identifying a likely onset of a viral infection. This would enable us to not only notify the VYVO smartwatch wearer so they can seek early treatment and self-isolate to protect their family and friends but also benefit the healthcare community as a whole. Using traditional research methods, a global field experiment of this magnitude could take years, Mr. Galdi continued but we believe that, by using our devices and technology, we have the potential to see meaningful results and possibly Project CEASE validation in a much shorter time frame.
Sean McVeigh, CEO of Helo Corp., said that, Although today COVID-19 detection is a high priority activity, this type of research and development is not new for us. Our VYVO smartwatches already provide personal alerts and supporting data to wearers and their guardians, when events such as atrial fibrillation, low blood oxygenation, elevated temperature or sleep apnea are detected. However, given the critical nature of this pandemic, our focus is on Project CEASE so we can make our contribution to science by providing readily available and real-time data set that will help identify the mechanism of action of this virus, minimize its impact and reduce transmission rates. We thank our prospective VYVO participants for their invaluable contribution and welcome the opportunity to invite and share our aggregated data with other experts, so we can all do our part to help stop the transmission of this virus.
About Helo Corp.
Helo Corp. is a technology company that provides wearable devices for use in the quantified-self, wellness market. Our wearable devices and related applications provide our wearers with health related knowledge acquired through self-tracking. Our Life Sensing TechnologyTM uses state-of-the-art sensors, enhanced signal processing and algorithms to collect and process specific data gathered from our smartwatch wearers; and it is embedded into our wearable devices that are designed, produced and sold into the wellness market through our marketing and distribution partner, Vyvo Pte. Ltd. and its distribution network. For further information, please see: www.helocorp.com.
Project CEASE is being managed by Vyvo Labs, the Quantified-Self Research Center of Helo Corps US subsidiary, Vyvo Technology Corp. For further information, please see www.vyvolabs.com.
Contact: investors@helocorp.com or +1 650-646-2193
Forward Looking Statement
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
San Francisco, California February 3, 2020 – Helo Corp. (OTC: HLOC) (the Company), a leading developer of wearable devices embedded with Life Sensing Technology and dedicated to improving wellness worldwide, today announced that it has signed a Letter of Intent with Vyvo Inc. to acquire certain strategic assets from Vyvo Inc. so that it can bring the Vyvo business into a public company.
Sean McVeigh, CEO of Helo Corp., said that, This transaction, which includes the acquisition of assets such as intellectual property, network software, strategic supplier and distribution contracts and debt forgiveness should enable us to quickly transition into the Vyvo business and also improve our balance sheet. We expect that this agreement will significantly increase our sales revenues as we will capture more of the customer transaction value when customers purchase our wearable devices, and we will also secure additional sales revenues from new products and services. Furthermore, the Company should be able to immediately recognize this additional revenue upon closing.
Upon closing, Fabio Galdi will be appointed CEO, Alessandro Senatore will be appointed COO and Sen McVeigh will continue as CFO of Helo Corp. Closing of this transaction is subject to the execution of definitive agreements on acceptable terms and the transfer of $88M HLOC shares to the ultimate beneficial owners of Vyvo Inc., namely Fabio Galdi, Alessandro and Sen McVeigh It is also subject to other customary conditions and is expected to occur no later than 30thApril, 2020. There can be no assurance that the acquisition will be completed in the stipulated time or at all.
Fabio Galdi said, We are extremely excited for the future at Vyvo. As a public company we will have the unique ability to tell our story and access capital in a much more efficient manner. It is an exciting time for us as we will have the technology and expertise all in-house to make a big impact on the $190B worldwide direct selling wellness market. We hope to lead the way in changing how the financial market views direct selling business model by combining our proven technology with Artificial Intelligence (AI) and producing a stream of next generation products that will improve our customers wellness. He continued, We are delighted with this agreement as it allows us to tie in and consolidate all of VYVO’s key activities under one company. The synergies are enormous. From a technology perspective, we can optimise the integration of AI into the Companys Life Sensing Technology so that we can produce more exciting, customized products that will bring significant and tangible wellness benefits to our customers. Also, our members will benefit financially from this agreement. It gives us the ability to open up new markets in USA, Asia, Europe and Russia, which will generate customer referral commissions for our existing and new members. Mr Galdi also confirmed that the Company will continue to operate under the HLOC ticker until it can change its name to Vyvo and update its ticker symbol.
We are a technology and network marketing company, using technology to create innovative solutions for the personalized health and wellness market worldwide. We are focused on developing consumer-oriented products that protect, monitor and empower people to improve their health through daily knowledge and informed choices. We create customized solutions to help our customers manage their most important asset, themselves and their life.
Our technology driven mission matches our network marketing soul. We are all about expanding concepts of personal growth and development, not only focusing on health but also on prosperity and economic wellbeing. For more information, please see www.vyvo.com.
About Helo Corp.
We are a technology company that provides wearable devices for use in the quantified-self wellness market. Our wearable devices and related applications provide our end-users with health related knowledge acquired through self-tracking. Our Life Sensing Technology uses state-of-the-art sensors, enhanced signal processing and algorithms to collect and process specific data from end-users; and it is embedded into branded wearable devices that are designed, produced and sold into the wellness market through our marketing and distribution partner, Vyvo Pte. Ltd. and its distribution network. For more information, see www.helocorp.com.
Forward Looking Statement
This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as may, “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” potential and similar statements. All statements other than statements of historical fact in this press release are forward-looking statements and involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These forward-looking statements are based on management’s current expectations, assumptions, estimates, and projections about the Company and the industry in which the Company operates, but involve a number of unknown risks and uncertainties. Further information regarding these and other risks is included in the Company’s filings with the OTC Markets and the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and actual results may differ materially from the anticipated results. You are urged to consider these factors carefully in evaluating the forward-looking statements contained herein and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements.
We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.
Other external services
We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Vimeo and Youtube video embeds:
Privacy Policy
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
An overview of santéPatch technology is explained in the figure above and in santéPatch’s 
Seán McVeigh, Helo’s Chief Executive Officer, confirmed that, “Although the pandemic has been difficult, bringing personal and business challenges, we are thankful to our employees, our customers and our Vyvo promoters worldwide who have helped deliver our record 2021 results. We are now well positioned for strong growth. This year,”he says, “we have been continually investing in hiring new employees, developing our technology and expanding our facilities to ensure sustained growth in our chosen markets. Up to now, all of our growth has been organic. We are now preparing to extend our strategic footprint as we plan to launch new markets in 2022. We expect to enter these new markets by acquisition, joint venture or with organic sales growth.”
About Helo Corp.
Excerpts from video where Nasdaq rotated Bay Area Fast 500 winning company logos on its massive Times Square Tower Video screen last Friday. Full video, click 
